体外膜肺氧合在心血管急危重症的临床应用The clinical application of extracorporeal membrane oxygenation in severe cardiovascular diseases
卢安东,潘晨亮,雷鹏,蔡玮婷,赵存瑞,王俊乾,王淑萍,张丽霞,张博,白明,张钲
摘要(Abstract):
目的总结体外膜肺氧合(ECMO)在心血管急危重症临床应用的经验,评价其疗效。方法纳入2019年3月至2019年9月兰州大学第一医院收治并行ECMO辅助治疗的患者24例。其中,经皮冠状动脉介入治疗(PCI)组12例均在手术室建立ECMO,心原性休克组12例均在冠心病重症监护室(CCU)建立ECMO。回顾性分析24例患者的临床资料。结果 PCI组12例均在导管室手术完成后顺利撤离ECMO(脱机率12/12),12例均存活出院(生存率12/12);ECMO辅助时间1.3~4(2.6±1.5)h,辅助流量1.7~2.8(2.1±0.4)L/min;2例联合应用主动脉内球囊反搏(IABP)治疗。PCI组完全再血管化达11例(11/12),1例因右冠状动脉慢性完全闭塞反复尝试后未开通。PCI组患者术后第7天左心室射血分数(LVEF)较术前差异无统计学意义(P>0.05)。心原性休克组12例患者中10例顺利脱离ECMO(脱机率10/12),8例存活出院(存活率8/12),2例成功撤除ECMO后死亡(下消化道出血1例,无法脱离IABP 1例);ECMO辅助时间73~223(139.2±46.6)h;术后第7天LVEF较术前明显增加(P<0.05)。24例患者均无机械故障及氧合器故障,无脱管,无下肢缺血坏死,无心脏压塞;共发生出血并发症11例。结论 ECMO是急危重症冠心病行PCI的重要的保驾护航手段之一,可以使得心原性休克患者获益,提高心原性休克生存率。高效的ECMO团队、ECMO时机的把握、精细化个体化管理、有效控制和预防并发症是ECMO救治成功的关键因素。
关键词(KeyWords): 体外膜肺氧合;心血管急危重症;经皮冠状动脉介入治疗;心原性休克;并发症
基金项目(Foundation): 甘肃省自然科学基金(17JR5RA268)
作者(Author): 卢安东,潘晨亮,雷鹏,蔡玮婷,赵存瑞,王俊乾,王淑萍,张丽霞,张博,白明,张钲
参考文献(References):
- [1] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017:a systematic analysis for the Global Burden of Disease Study 2017. Lancet,2019,394(10204):1145-1158.
- [2]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要.中国循环杂志,2019,34:209-220.
- [3] Van Diepen S, Thiele H. An overview of international cardiogenic shock guidelines and application in clinical practice. Curr Opin Crit Care, 2019,25(4):365-370.
- [4] Unverzagt S, Buerke M, de Waha A, et al. Intra-aortic balloon pump counterpulsation(IABP)for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev,2015,27(3):CD007398.
- [5] Napp LC, Kuhn C, Bauersachs J. ECMO in cardiac arrest and cardiogenic shock. Herz, 2017,42(1):27-44.
- [6] Rao P, Khalpey Z, Smith R, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest.Circ Heart Fail,2018,11(9):e004905.
- [7] Quweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock:a systematic review and meta-analysis. Intensive Care Med,2016,42(12):1922-1934.
- [8] Myat A, Patel N, Tehrani S, et al. Percutaneous circulatory assist devices for high-risk coronary intervention. JACC Cardiovasc Interv,2015,8(2):229-244.
- [9] Rihal CS, Naidu SS, Givertz MM, et al. Clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Am Coll Cardiol,2015,65(19):e7-e26.
- [10]龙村.体外膜肺氧合循环支持专家共识.中国体外循环杂志,2014,12(2):65-67.
- [11] Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract,2012,120:c179-c184.
- [12] Guerrero-Miranda CY, Hall SA. Cardiac catheterization and percutaneous intervention procedures on extracorporeal membrane oxygenation support. Ann Cardiothorac Surg,2019,8(1):123-128.
- [13] Chung SY, Tong MS, Sheu JJ, et al. Short-term and longterm prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention. Int J Cardiol,2016,223:412-417.
- [14]高好考,陈根锐,程亮,等.体外膜肺氧合联合主动脉内球囊反搏在高危经皮冠状动脉介入治疗中的应用.中国介入心脏病学杂志,2019,27(8):433-439.
- [15] Thomas J, Kostousov V, Teruya J. Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation.Semin Thromb Hemost,2018,44(1):20-29.
- [16] Mazzeffi M, Kiefer J, Greenwood J, et al. Epidemiology of gastrointestinal bleeding in adult patients on extracorporeal life support. Intensive Care Med,2015,41(11):2015.
- [17] Juo YY, Skancke M, Sanaiha Y, et al. Efficacy of distal perfusion cannulae in preventing limb ischemia during extracorporeal membrane oxygenation:a systematic review and meta-analysis.Artif Organs,2017,41(11):E263-E273.
- [18] Lamb KM, Hirose H. Vascular Complications in extracoporeal membrane oxygenation. Crit Care Clin,2017,33(4):813-824.
- [19] Biffi S, Di Bella S, Scaravilli V, et al. Infections during extracorporeal membrane oxygenation:epidemiology, risk factors, pathogenesis and prevention. Int J Antimicrob Agents,2017,50(1):9-16.
- [20] Cavarocchi NC. Introduction to extracorporeal membrane oxygenation. Crit Care Clin,2017,33(4):763-766.